Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Shock

dichlororibofuranosylbenzimidazole has been researched along with Shock in 1 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Price, BD1
Calderwood, SK1

Other Studies

1 other study available for dichlororibofuranosylbenzimidazole and Shock

ArticleYear
Heat-induced transcription from RNA polymerases II and III and HSF binding activity are co-ordinately regulated by the products of the heat shock genes.
    Journal of cellular physiology, 1992, Volume: 153, Issue:2

    Topics: Animals; Cycloheximide; Dichlororibofuranosylbenzimidazole; DNA-Binding Proteins; Drug Stability; Ge

1992